Predictive Clinical Factors in the Diagnosis of Gastrointestinal Kaposi's Sarcoma and Its Endoscopic Severity
Open Access
- 30 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e46967
Abstract
The diagnosis of gastrointestinal (GI) involvement in Kaposi's sarcoma (KS) is important to make because the need for treatment depends on the extent of the disease. Moreover, severe GI lesions can cause serious complications. Endoscopy with biopsy is an extremely useful method to diagnose GI-KS. However, determining the indications for endoscopy is difficult because KS can occur without GI symptoms or cutaneous KS. This study sought to clarify predictive clinical factors for GI-KS and its severity on endoscopy. A total of 1,027 HIV-infected patients who underwent endoscopy were analyzed. Sexual behavior, CD4 count, HIV RNA, history of highly active antiretroviral therapy (HAART), GI symptoms, and cutaneous KS were assessed. Endoscopic severity including bulky tumor, ulceration, and number of lesions were evaluated. Thirty-three patients had GI-KS and 46 patients cutaneous KS. Among the GI-KS patients, 78.8% (26/33) had no GI symptoms and 24.2% (8/33) had no cutaneous KS. Univariate analysis identified men who have sex with men (MSM), CD4 <100 cells/µL, HIV RNA ≥10,000 copies/mL, no history of HAART, and cutaneous KS were significantly associated with GI-KS. Among these factors, cutaneous KS was closely related to GI-KS on multivariable analysis. Among patients without cutaneous KS, MSM and CD4 count <100 cells/µL were the only independent clinical factors related to GI-KS. Bulky tumor was significantly associated with CD4 <100 cells/µL and large number of lesions was significantly associated with HIV-RNA ≥10,000 copies/mL. To diagnose GI-KS, clinical factors need to be considered before endoscopy. The presence of GI symptoms is not useful in predicting GI-KS. MSM and CD4 count <100 cells/µL are predictive factors among patients without cutaneous KS. Caution should be exercised especially in patients with low CD4 counts or high HIV viral loads as they are more likely to develop severe GI-KS lesions.Keywords
This publication has 31 references indexed in Scilit:
- Kaposi's Sarcoma Presenting as a Bulky Tumor Mass of the ColonClinical Gastroenterology and Hepatology, 2011
- AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort studyAIDS, 2010
- Kaposi Sarcoma Incidence and Survival Among HIV-Infected Homosexual Men After HIV SeroconversionJNCI: Journal of the National Cancer Institute, 2010
- Profile of Patients With Kaposi's Sarcoma in the Era of Highly Active Antiretroviral TherapyJournal of Clinical Oncology, 2005
- The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003Cancer, 2004
- AIDS-Related Kaposi’s Sarcoma: Evaluation of Potential New Prognostic Factors and Assessment of the AIDS Clinical Trial Group Staging System in the Haart Era—the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naïve From AntiretroviralsJournal of Clinical Oncology, 2003
- Kaposi's sarcoma of internal organs. A multiparameter study of 86 casesCancer, 1995
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Moriz Kaposi, M.DCA: A Cancer Journal for Clinicians, 1982
- Kaposiʼs SarcomaJournal of Clinical Gastroenterology, 1982